Johnson & Johnson has reported on Tuesday net earnings and diluted earnings per share for the third quarter of 2016 of$4.3 billion and $1.53, respectively. Third quarter 2015 net earnings included after-tax intangible amortization expense of approximately $0.4 billion and a charge for after-tax special items of approximately $0.4 billion. 223 more words
Tags » Johnson & Johnson
Insurers and health care providers had hoped a new class of medicines called biosimilars would keep a check on high drug prices and reduce health spending in America. 508 more words
Johnson & Johnson on Tuesday reported a better-than-expected quarterly profit and said its phamaceutical business will keep prospering despite the threatened launch of a competitor for its blockbuster Remicade arthritis drug. 356 more words
NEW YORK (CBSNewYork) — Johnson and Johnson says its OneTouch Insulin Pump has a big bug that makes it vulnerable to hackers.
According to cybersecurity Rapid7, Inc. 97 more words
(Reuters) – Johnson & Johnson is telling patients that it has learned of a security vulnerability in one of its insulin pumps that a hacker could exploit to overdose diabetic patients with insulin, though it describes the risk as low. 685 more words